The 9-Month Medical Weight-Loss Programme combines medically prescribed Mounjaro therapy with monthly Weight-Loss Support IV infusions to support metabolic health throughout treatment.

Clinical Oversight

All treatment is provided under medical supervision, and medication suitability and dosing are determined through clinical assessment by Dr De Bruyn.

9-Month Medical Weight-Loss Programme (Mounjaro + IV Therapy)

R 116 000,00

Months 1–3 2.5 mg Initiation Phase
Treatment begins with the 2.5 mg dose of Mounjaro to allow the body to adapt to therapy while appetite regulation and metabolic changes begin under clinical supervision. 12 treatments delivered during this phase

Months 4–6 5 mg Progression Phase
The dosage increases to 5 mg to maintain treatment effectiveness as the body adjusts to therapy and metabolic response continues to develop. 12 treatments delivered during this phase

Months 7–9 7.5 mg Advanced Phase
The final phase increases the dosage to 7.5 mg to help sustain therapeutic impact and support continued weight-management progress. 12 treatments delivered during this phase

9-Month Medical Weight-Loss Programme (Mounjaro + IV Therapy)

Treatment Pathway